Dampened dopamine-mediated neuromodulation in prefrontal cortex of fragile X mice

Journal of Physiology

Volumn 591, Issue 4, 2013, Pages 1133-1143

  Paul, Kush ^a,b   Venkitaramani, Deepa V ^b   Cox, Charles L ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; FRAGILE X MENTAL RETARDATION PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DOPAMINERGIC SYSTEM; FACILITATION; FEMALE; FRAGILE X SYNDROME; INHIBITORY POSTSYNAPTIC POTENTIAL; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL STIMULATION; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; TISSUE LEVEL; WILD TYPE;

ANIMALS; DOPAMINE; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MICE; MICE, KNOCKOUT; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RECEPTORS, DOPAMINE; SYNAPTIC TRANSMISSION;

EID: 84873739255     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.241067     Document Type: Article

References (51)

1. Bagni C & Greenough WT (2005). From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci 6, 376-387.
2. Berry-Kravis E, Lewin F, Wuu J, Leehey M, Hagerman R, Hagerman P & Goetz C (2002). Tremor and ataxia in adult fragile X premutation carriers: blinded videotape evaluation. Ann Neurol 52, S86.
3. Bhattacharyya A, McMillan E, Wallace K, Tubon TC, Capowski EE & Svendsen CN (2008). Normal neurogenesis but abnormal gene expression in human fragile X cortical progenitor cells. Stem Cells Dev 17, 107-117.
4. Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin XK, Feng Y, Wilkinson KD, Keene JD, Darnell RB & Warren ST (2001). Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107, 477-487.
5. Brown WT (1996). The FRAXE syndrome: is it time for routine screening Am J Hum Genet 58, 903-905.
6. Casten KS, Gray AC & Burwell RD (2011). Discrimination learning and attentional set formation in a mouse model of fragile X. Behav Neurosci 125, 473-479.
7. Cauller LJ & Connors BW (1994). Synaptic physiology of horizontal afferents to layer I in slices of rat SI neocortex. J Neurosci 14, 751-762.
8. Cornish KM, Munir F & Cross G (2001). Differential impact of the FMR-1 full mutation on memory and attention functioning: a neuropsychological perspective. J Cogn Neurosci 13, 144-150.
9. Cox CL, Huguenard JR & Prince DA. (1995). Cholecystokinin depolarizes rat thalamic reticular neurons by suppressing a K+ conductance. J Neurophysiol 74, 990-1000.
10. Crofts HS, Dalley JW, Collins P, Van Denderen JCM, Everitt BJ, Robbins TW & Roberts AC (2001). Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex 11, 1015-1026.
11. Dockendorff TC, Su HS, McBride SMJ, Yang ZH, Choi CH, Siwicki KK, Sehgal A & Jongens TA (2002). Drosophila lacking dfmr1 activity show defects in circadian output and fail to maintain courtship interest. Neuron 34, 973-984.
12. Durstewitz D, Seamans JK & Sejnowski TJ (2000). Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol 83, 1733-1750.
13. Eberhart DE, Malter HE, Feng Y & Warren ST (1996). The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5, 1083-1091.
14. Egan MF & Weinberger DR (1997). Neurobiology of schizophrenia. Curr Opin Neurobiol 7, 701-707.
15. Feng Y, Gutekunst CA, Eberhart DE, Yi H, Warren ST & Hersch SM (1997). Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17, 1539-1547.
16. Fryns JP (1984). The fragile X-syndrome - a study of 83 families. Clin Genet 26, 497-528.
17. Govindaiah & Cox CL (2004). Synaptic activation of metabotropic glutamate receptors regulates dendritic outputs of thalamic interneurons. Neuron 41, 611-623.
18. Hagerman RJ (1996). Fragile X syndrome. Child Adolesc Psychiatr Clin N Am 5, 895-911.
19. Hooper SR, Hatton D, Sideris J, Sullivan K, Hammer J, Schaaf J, Mirrett P, Ornstein PA & Bailey DB (2008). Executive functions in young males fragile X syndrome in comparison to mental age-matched with controls: baseline findings from a longitudinal study. Neuropsychology 22, 36-47.
20. Keenan JM & Simon JA (2004). Inference deficits in women with fragile X syndrome: a problem in working memory. Cogn Neuropsychol 21, 579-596.
21. Kelley DJ, Davidson RJ, Elliott JL, Lahvis GP, Yin JCP & Bhattacharyya A (2007). The cyclic AMP cascade is altered in the fragile X nervous system. PloS One 2, e931.
22. Krishnan B, Centeno M, Pollandt S, Fu Y, Genzer K, Liu J, Gallagher JP & Shinnick-Gallagher P (2010). Dopamine receptor mechanisms mediate corticotropin-releasing factor-induced long-term potentiation in the rat amygdala following cocaine withdrawal. Eur J Neurosci 31, 1027-1042.
23. Lanfranchi S, Cornoldi C, Drigo S & Vianello R (2009). Working memory in individuals with fragile X syndrome. Child Neuropsychol 15, 105-119.
24. Largo RH & Schinzel A (1985). Developmental and behavioral disturbances in 13 boys with fragile X-syndrome. Eur J Pediatr 143, 269-275.
25. Miyashiro KY, Beckel-Mitchener A, Purk TP, Becker KG, Barret T, Liu L, Carbonetto S, Weiler IJ, Greenough WT & Eberwine J. (2003). RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmrl null mice. Neuron 37, 417-431.
26. Moon J, Beaudin AE, Verosky S, Driscoll LL, Weiskopf M, Levitsky DA, Crnic LS & Strupp BJ (2006). Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome. Behav Neurosci 120, 1367-1379.
27. Munir F, Comish KM & Wilding J (2000a). A neuropsychological profile of attention and hyperactivity in boys with fragile-X syndrome: implications for clinical intervention. J Intellect Disabil Res 44, 405.
28. Munir F, Cornish KM & Wilding J (2000b). A neuropsychological profile of attention deficits in young males with fragile X syndrome. Neuropsychologia 38, 1261-1270.
29. Munir F, Cornish KM & Wilding J (2000c). Nature of the working memory deficit in fragile-X syndrome. Brain Cogn 44, 387-401.
30. O'Grada C & Dinan T (2007). Executive function in schizophrenia: what impact do antipsychotics have Hum Psychopharmacol 22, 397-406.
31. Ornstein PA, Schaaf JM, Hooper SR, Hatton DD, Mirrett P & Bailey DB (2008). Memory skills of boys with fragile X syndrome. Am J Ment Retard 113, 453-465.
32. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT & Nelson DL (1991). Absence of expression of the Fmr-1 gene in fragile-X syndrome. Cell 66, 817-822.
33. Rao SG, Williams GV & Goldman-Rakic PS (1999). Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. J Neurophysiol 81, 1903-1916.
34. A blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20, 485-494.
35. Robbins TW & Arnsten AFT (2009). The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Ann Rev Neurosci 32, 267-287.
36. Robbins TW & Roberts AC (2007). Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex 17, I151-I160.
37. Roberts JE, Symons FJ, Johnson AM, Hatton DD & Boccia ML (2005). Blink rate in boys with fragile X syndrome: preliminary evidence for altered dopamine function. J Intellect Disabil Res 49, 647-656.
38. Scerif G, Cornish K, Cole V, Longhi E & Karmiloff-Smith A (2009). Unimodal and cross-modal attention deficits in fragile X syndrome: developmental trajectories and predictors of within-group heterogeneity. J Intellect Disabil Res 53, 837.
39. Schafe GE, Atkins CM, Swank MW, Bauer EP, Sweatt JD & Ledoux JE (2000). Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of Pavlovian fear conditioning. J Neurosci 20, 8177-8187.
40. Seamans JK, Gorelova N, Durstewitz D & Yang CR (2001). Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci 21, 3628-3638.
41. Seamans JK & Yang CR (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74, 1-57.
42. Trantham-Davidson H, Neely LC, Lavin A, & Seamans JK (2004). Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J Neurosci 24, 10652-10659.
43. Turner G, Webb T, Wake S & Robinson H (1996). Prevalence of fragile X syndrome. Am J Med Genet 64, 196-197.
44. Veenema H, Veenem T & Geraedts JPM (1987). The fragile X-syndrome in a large family. 2. Psychological investigations. J Med Genet 24, 32-38.
45. Ventura R, Pascucci T, Catania MV, Musumeci SA & Puglisi-Allegra S (2004). Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol 15, 433-442.
46. Verheij C, Bakker CE, Degraaff E, Keulemans J, Willemsen R, Verkerk AJMH, Galjaard H, Reuser AJJ, Hoogeveen AT & Oostra BA (1993). Characterization and localization of the Fmr-1 gene-product associated with fragile-X syndrome. Nature 363, 722-724.
47. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV & Arnsten AFT (2007). Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10, 376-384.
48. Wang H, Wu LJ, Kim SS, Lee FJS, Gong B, Toyoda H, Ren M, Shang YZ, Xu H, Liu F, Zhao MG & Zhuo M (2008). FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59, 634-647.
49. Yan QJ, Asafo-Adjei PK, Arnold HM, Brown RE & Bauchwitz RP (2004). A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav 3, 337-359.
50. Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, O'Shea DJ, Sohal VS, Goshen I, Finkelstein J, Paz JT, Stehfest K, Fudim R, Ramakrishnan C, Huguenard JR, Hegemann P & Deisseroth K (2011). Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171-178.
51. Zhang YQ, Friedman DB, Wang Z, Woodruff E, Pan L Y, O'Donnell J & Broadie K (2005). Protein expression profiling of the Drosophila fragile X mutant brain reveals up-regulation of monoamine synthesis. Mol Cell Proteomics 4, 278-290.